Tumors often develop resistance to targeted therapies by adapting or activating alternative pathways, a process involving cellular plasticity and the reactivation of developmental signaling pathways.

Authors

• Person: Not available Organization: Frontiers
  Emerging Therapeutics in Precision Cancer Medicine - Frontiers

Sources

• Emerging Therapeutics in Precision Cancer Medicine - Frontiers www.frontiersin.org Frontiers via serper

Referenced by nodes (1)

• targeted cancer therapy concept